Previous Page  10 / 18 Next Page
Information
Show Menu
Previous Page 10 / 18 Next Page
Page Background

Nanobiotechnology 2018

Page 28

Nano Research & Applications

ISSN: 2471-9838

E u r o S c i C o n C o n f e r e n c e o n

Nanotech & Nanobiotechnology

J u l y 1 2 - 1 3 , 2 0 1 8

P a r i s , F r a n c e

O

ne of the major unsolved problems in pharmaceutical drug development is

the poor water solubility of many active pharmaceutical ingredients (APIs)

and hence reduced bioavailability. One of the preferred strategies to address

this problem was to leverage the increased solubility with decreasing drug

particle size. However, an ideal solution would be to eliminate the problem of

solubility entirely, by reducing the API size to clusters of a fewmolecules, bound

by weak, Vander Waal’s forces that would readily dissociate into molecules,

during enteral or parenteral drug delivery process. In order to have commercial

impact, such molecular clusters should also be produced in sufficiently high

yield. In our research, we have successfully addressed both these challenges.

We report the precipitation of molecular clusters of ibuprofen using a rapid

expansion of super critical solution (RESS) system. Our custom designed

liquid N

2

cooled collection process of the molecular clusters embedded in

dry ice, resulted in yields of up to 80% (w/w). Ambient dissolution of the dry

ice in deionized water resulted in a stable dispersion, for up to six months,

as confirmed by DLS and AFM characterizations. DLS measurements showed

that PEI surfactant (M

w

~400,000) produced the smallest particle size of 7 nm,

with a narrow size distribution of ±3 nm. Drop casting of these dispersions

on silicon and sapphire substrates resulted in high quality, liquid like viscous

films as observed by optical microscopy and AFM. XRD and confocal Raman

characterizations confirmed that the molecular clusters retained their

chemical identity of ibuprofen. Besides its scientific importance, this invention

is expected to open up new drug delivery platforms.

Biography

Sudhir Kumar Sharma obtained his Masters’ degree (MSc

Physics and M. Tech-Materials) from Department of Physics,

Barkatullah University Bhopal, India. He received his PhD from

the Indian Institute of Science Bangalore, India. He joined as

Postdoc fellow at Centre for Nano Science and Engineering

(CeNSE), IISc. Bangalore, India. Later he moved to New York

University Abu Dhabi UAE (NYU Abu Dhabi) as a Research

Associate in 2013. Currently, he is working as a Research

Scientist at NYU Abu Dhabi. His publication record includes

more than 30 journals and 60 conference presentations. His

research interest includes implementation of supercritical

technologies for nanoparticle synthesis, smart materials

for micro-sensors and actuators, micro/nano- fabrications,

vacuum science, and thin film technology.

sks16@nyu.edu

Synthesis of sub-10 nm ibuprofen drug molecular clusters via

RESS processing

Sudhir Kumar Sharma and Ramesh Jagannathan

New York University Abu Dhabi, UAE

Sudhir Kumar Sharma et al., Nano Res Appl 2018, Volume 4

DOI: 10.21767/2471-9838-C2-011